From Psychopharmacology to Neuropsychopharmacology in the 1980s and the Story of CINP, as Told in AutobiographyThomas A. Ban, David Healy, Edward Shorter This series covers in autobiographical accounts the first fifty years in the history of neuropsychopharmacology. The autobiographies in Volume I, (The Rise of Psychopharmacology and the Story of CINP) are from psychopharmacologists who began their professional careers in the 1950s and 1960s; in Volume II (The Triumph of Psychopharmacology and the Story of CINP), from those who started in the 1970s; in Volume III (From Psychopharmacology to Neuropsychopharmacology in the 1980s and the Story of CINP), who started in the 1980s; and in Volume IV (Reflections on Twentieth-Century Psychopharmacology), who started in the 1990s. At the core of each volume are personal accounts in which the contributions of the scientists, are at the center of the reflections, but also include several sections in which the reflections are focused on the mainstream of events, particular areas of research, individuals and organizations. The series was the extension of an effort by CINP's History Committee, during the chairmanship of Tom Ban, to document both the history of the College and the enire field. It was co-edited by Ban, David Healy and Edward Shorter. Its publication was supported by the College primarily from non-restricted publication grants received from Pierre Fabre, Janssen Pharmaceutica and Research Foundation,Inc., and Janssen Phamaceutica International in Collaboration with Organon International. |
From inside the book
Try this search over all volumes: nd
Results 1-0 of 0
Contents
Preface | 11 |
Psychopharmacology after the 1960s United Kingdom | 18 |
Plotting the Course of My Lifes Professional and Spiritual | 25 |
Copyright | |
38 other sections not shown
Common terms and phrases
ACNP activity affective disorders Alec Coppen American antidepressant effect antipsychotic became behavior benzodiazepines Biological Psychiatry bipolar disorder brain Bunney Center chaired chlorpromazine chronic CINP Congress clinical pharmacology clinical research clinical trials clozapine cognitive collaboration colleagues committee Crow TJ David Healy department of psychiatry depressed patients director discovery disease dopamine dosages doses endogenous experience findings Geigy haloperidol Hindmarch Hospital imipramine inhibitors interest investigators Japan Journal of Psychiatry Kielholz laboratory Largactil lithium Max Hamilton medical school Medicine meeting Mental Health metabolites monoamine oxidase Münsterlingen National Institute neuroleptic Neuropsychopharmacology neuroscience neurotransmitters NIMH nitrous oxide organization paper Paul Schmidlin pharmacokinetics pharmacology placebo plasma professor of psychiatry psychoactive drugs psychopharmacology psychosis psychotropic drugs published Rafaelsen receptor residency response Roland Kuhn role schizophrenia schizophrenic patients Science serotonin session side effects substance symposium symptoms syndrome tardive dyskinesia therapeutic therapy University Youdim